---
title: "CTNNB1"
date: 2023-05-12 00:00:00
layout: post
categories: Gene
summary: "## Gene: CTNNB1"
tags: ['CTNNB1', 'BetaCatenin', 'WntSignaling', 'Cancer', 'Treatment', 'DrugResponse', 'GeneticMutations', 'Prognosis']
---

## Gene: CTNNB1
- **Function:** The CTNNB1 gene encodes for the beta-catenin protein, which plays a crucial role in the Wnt signaling pathway and cell-cell adhesion. It regulates cell proliferation and differentiation during embryonic development and adult tissue homeostasis. 

- **External IDs and Genomic Location:**
    - HGNC: 2500
    - NCBI Entrez: 1499
    - Ensembl: ENSG00000168036
    - OMIM: 116806
    - UniProtKB/Swiss-Prot: P35222
    - Genomic location: Chromosome 3, 41,210,503 - 41,247,863 bp

- **Aliases:** 
    - Beta-catenin
    - CTNNB 
    - MRD19 
    - armadillo protein p120

- **AA mutation list and mutation type with dbSNP ID:**
    - c.98T>C (p.Ser33Pro) - dbSNP ID: rs121913529
    - c.121A>G (p.Thr41Ala) - dbSNP ID: rs267607025
    - c.133T>A (p.Ser45Thr) - dbSNP ID: rs121913530
    - c.179G>A (p.Ala60Thr) - dbSNP ID: rs267607026
    - c.183A>G (p.Ser61Gly) - dbSNP ID: rs121913531
    - c.335C>T (p.Arg112Ter) - dbSNP ID: rs267607027

- **Somatic SNVs/InDels with dbSNP ID:**
    - c.104T>C (p.Leu35Pro) - dbSNP ID: rs772634108
    - c.98_99delCT (p.Ser33Leufs*3) - dbSNP ID: rs762631967
    - c.110G>T (p.Gly37Val) - dbSNP ID: rs1800266
    - c.71C>A (p.Asn24Lys) - dbSNP ID: rs1800263

- **Related Diseases:**
    - Colorectal cancer
    - Epithelial ovarian cancer
    - Hepatocellular carcinoma
    - Medulloblastoma
    - Pilomatricoma
    - Protein-losing enteropathy
    - Spermatocytic seminoma

- **Treatment and Prognosis:**
    - The inhibition of the beta-catenin pathway is a potential treatment strategy against various cancers, including colorectal cancer, hepatocellular carcinoma, breast cancer, and lung cancer. 

- **Drug Response:**
    - XAV939, a small molecule inhibitor of CTNNB1, has been shown to inhibit the Wnt/beta-catenin pathway and suppress tumor growth in preclinical studies.

- **References:**
    - Busby, T., & Kummar, S. (2015). Targeting the Wnt pathway in cancer therapeutics. Oncologist, 20(10), 1189–1198. doi: 10.1634/theoncologist.2015-0151
    - CTNNB1 gene. (n.d.). Genetics Home Reference. Retrieved from [Click](https://ghr.nlm.nih.gov/gene/CTNNB1)
    - Sveen, A., & Lothe, R. A. (2019). Biology and clinical impact of the β-catenin‒activated pathway in colorectal cancer. Scandinavian Journal of Gastroenterology, 54(1), 1-8. doi: 10.1080/00365521.2018.1507330

**_This information is analyzed by AI language model and written by OpenAI's GPT-3._**